Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Anti-TNF therapy can cause hair loss and skin issues.

Blocking interferon-gamma might help treat various autoimmune diseases.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Some Korean herb extracts can reduce inflammation and are safe for skin use.

Osmanthus fragrans var. aurantiacus Makino may help treat inflammation due to its antioxidative and anti-inflammatory properties.

Melatonin reduced oxidative damage, inflammation, and protected hair cells in scalded rats.

Ginger peel polysaccharides modified with zinc effectively reduce inflammation.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Psoriasis can cause temporary or permanent hair loss.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Hair loss is common in IBD patients, and some medications may lower the risk.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.